Publications

  1. Zhao Y, Foster NR, Meyers JP, Thomas SP, Northfelt DW, Rowland KM Jr, Mattar BI, Johnson DB, Molina JR, Mandrekar SJ, Schild SE, Bearden JD 3rd, Aubry MC, Adjei AA. A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin and Concurrent Thoracic Radiation Therapy for Non-Small Cell Lung Cancer: NCCTG-N0321. J Thorac Oncol. 2014 Sep 22.
    View PubMed
  2. Haluska P, Menefee M, Plimack ER, Rosenberg J, Northfelt D, LaVallee T, Shi L, Yu XQ, Burke P, Huang J, Viner J, McDevitt J, LoRusso P. Phase I Dose-Escalation Study of MEDI-573, a Bispecific, Antiligand Monoclonal Antibody against IGFI and IGFII, in Patients with Advanced Solid Tumors. Clin Cancer Res. 2014 Sep 15; 20(18):4747-57. Epub 2014 Jul 14.
    View PubMed
  3. Ingle JN, Kalari K, Buzdar AU, Robson ME, Goetz MP, Desta Z, Barman P, Dudenkov TT, Northfelt DW, Perez EA, Flockhart DA, Williard CV, Wang L, Weinshilboum RM. Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole. Steroids. 2014 Aug 24. [Epub ahead of print]
    View PubMed
  4. Ingle JN, Kr K, Buzdar AU, Robson ME, Goetz MP, Desta Z, Barman P, Dudenkov TT, Northfelt DW, Perez EA, Flockhart DA, Williard CV, Wang L, Weinshilboum RM. Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole. Steroids. 2014 Aug 24.
    View PubMed
  5. Khera N, Chang YH, Slack J, Fauble V, Leis JF, Noel P, Sproat L, Palmer J, Adams R, Fitch T, Northfelt D, Guy M, Tilburt J, Mikhael J. Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantation. Leuk Lymphoma. 2014 Aug 20; 1-6.
    View PubMed
  6. Costello BA, Borad MJ, Qi Y, Kim GP, Northfelt DW, Erlichman C, Alberts SR. Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors. Invest New Drugs. 2014 Aug; 32(4):710-6. Epub 2014 Apr 18.
    View PubMed
  7. Northfelt DW, Ramanathan RK, Cohen PA, Von Hoff DD, Weiss GJ, Dietsch GN, Manjarrez KL, Randall TD, Hershberg RM. A Phase I Dose-Finding Study of the Novel Toll-like Receptor 8 Agonist VTX-2337 in Adult Subjects with Advanced Solid Tumors or Lymphoma. Clin Cancer Res. 2014 Jul 15; 20(14):3683-91. Epub 2014 May 07.
    View PubMed
  8. Curtis KK, Sarantopoulos J, Northfelt DW, Weiss GJ, Barnhart KM, Whisnant JK, Leuschner C, Alila H, Borad MJ, Ramanathan RK. Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors. Cancer Chemother Pharmacol. 2014 May; 73(5):931-41. Epub 2014 Mar 08.
    View PubMed
  9. Northfelt DW, Allred JB, Liu HS, Hobday TJ, Rodacker MW, Lyss AP, Fitch TR, Perez EA. Phase 2 trial of paclitaxel polyglumex with capecitabine for metastatic breast cancer. American Journal Of Clinical Oncology-cancer Clinical Trials. 2014 Apr; 37(2):167-71.
  10. Ruddy KJ, O'Neill A, Miller KD, Schneider BP, Baker E, Sparano JA, Dang C, Northfelt DW, Sledge GW Jr, Partridge AH. Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103. Breast Cancer Res Treat. 2014 Apr; 144(3):591-7. Epub 2014 Mar 02.
    View PubMed
  11. Chiappori A, Williams C, Northfelt DW, Adams JW, Malik S, Edelman MJ, Rosen P, Van Echo DA, Berger MS, Haura EB. Obatoclax mesylate, a pan-bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancer. J Thorac Oncol. 2014 Jan; 9(1):121-5.
    View PubMed
  12. Mookadam F, Sharma A, Lee HR, Northfelt DW. Intersection of cardiology and oncology clinical practices. Front Oncol. 2014; 4:259. Epub 2014 Sep 24.
    View PubMed
  13. Roy V, Pockaj BA, Allred JB, Apsey H, Northfelt DW, Nikcevich D, Mattar B, Perez EA. A Phase II trial of docetaxel and carboplatin administered every 2 weeks as preoperative therapy for stage II or III breast cancer: NCCTG study N0338. Am J Clin Oncol. 2013 Dec; 36(6):540-4.
    View PubMed
  14. Mahadevan D, Northfelt DW, Chalasani P, Rensvold D, Kurtin S, Von Hoff DD, Borad MJ, Tibes R. Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphoma. Int J Clin Oncol. 2013 Oct; 18(5):934-41. Epub 2012 Oct 11
    View PubMed
  15. Tan WW, Dueck AC, Flynn P, Steen P, Anderson D, Rowland K, Northfelt D, Perez EA. N0539 phase II trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: a North Central Cancer Treatment Group (now Alliance) trial. Ann Oncol. 2013 Oct; 24(10):2548-54. Epub 2013 Jun 24.
    View PubMed
  16. Schenk E, Hendrickson AE, Northfelt D, Toft DO, Ames MM, Menefee M, Satele D, Qin R, Erlichman C. Phase I study of tanespimycin in combination with bortezomib in patients with advanced solid malignancies. Invest New Drugs. 2013 Oct; 31(5):1251-6. Epub 2013 Mar 31.
    View PubMed
  17. Swain SM, Tang G, Geyer CE Jr, Rastogi P, Atkins JN, Donnellan PP, Fehrenbacher L, Azar CA, Robidoux A, Polikoff JA, Brufsky AM, Biggs DD, Levine EA, Zapas JL, Provencher L, Northfelt DW, Paik S, Costantino JP, Mamounas EP, Wolmark N. Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial. J Clin Oncol. 2013 Sep 10; 31(26):3197-204. Epub 2013 Aug 12.
    View PubMed
  18. Galanis E, Anderson SK, Lafky JM, Uhm JH, Giannini C, Kumar SK, Kimlinger TK, Northfelt DW, Flynn PJ, Jaeckle KA, Kaufmann TJ, Buckner JC. Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): a north central cancer treatment group trial. Clin Cancer Res. 2013 Sep 1; 19(17):4816-23. Epub 2013 Jul 05.
    View PubMed
  19. Cherington C, Schuster SR, Kundranda M, Valdez R, Mesa RA, Northfelt DW. A surprising cause of masses in the chest. Am J Hematol. 2013 Jun; 88(6):518-21. Epub 2012 Oct 17.
    View PubMed
  20. Sekulic A, Mangold AR, Northfelt DW, LoRusso PM. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway. Curr Opin Oncol. 2013 May; 25(3):218-23.
    View PubMed
  21. Liu M, Ingle JN, Fridley BL, Buzdar AU, Robson ME, Kubo M, Wang L, Batzler A, Jenkins GD, Pietrzak TL, Carlson EE, Goetz MP, Northfelt DW, Perez EA, Williard CV, Schaid DJ, Nakamura Y, Weinshilboum RM. TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression. Mol Endocrinol. 2013 Apr; 27(4):657-70. Epub 2013 Mar 21.
    View PubMed
  22. Moreno-Aspitia A, Dueck AC, Ghanem-Canete I, Patel T, Dakhil S, Johnson D, Franco S, Kahanic S, Colon-Otero G, Tenner KS, Rodeheffer R, McCullough AE, Jenkins RB, Palmieri FM, Northfelt D, Perez EA. RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer. Breast Cancer Res Treat. 2013 Apr; 138(2):427-35. Epub 2013 Mar 12.
    View PubMed
  23. Forero-Torres A, Bartlett N, Beaven A, Myint H, Nasta S, Northfelt DW, Whiting NC, Drachman JG, Lobuglio AF, Moskowitz CH. Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma. Leuk Lymphoma. 2013 Feb; 54(2):277-83. Epub 2012 Sep 08.
    View PubMed
  24. Northfelt DW, Allred JB, Liu H, Hobday TJ, Rodacker MW, Lyss AP, Fitch TR, Perez EA, for the North Central Cancer Treatment Group. Phase 2 Trial of Paclitaxel Polyglumex with Capecitabine for Metastatic Breast Cancer. Am J Clin Oncol. 2012 Dec 01. [Epub ahead of print]
    View PubMed
  25. Sideras K, Dueck AC, Hobday TJ, Rowland KM Jr, Allred JB, Northfelt DW, Lingle WL, Behrens RJ, Fitch TR, Nikcevich DA, Perez EA. North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane. Clin Breast Cancer. 2012 Dec; 12(6):387-91. Epub 2012 Oct 17.
    View PubMed
  26. Haakinson DJ, Leeds SG, Dueck AC, Gray RJ, Wasif N, Stucky CC, Northfelt DW, Apsey HA, Pockaj B. The impact of obesity on breast cancer: a retrospective review. Ann Surg Oncol. 2012 Sep; 19(9):3012-8. Epub 2012 Mar 27.
    View PubMed
  27. Philip PA, Mahoney MR, Holen KD, Northfelt DW, Pitot HC, Picus J, Flynn PJ, Erlichman C. Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer. Cancer. 2012 May 1; 118(9):2424-30. Epub 2011 Sep 27.
    View PubMed
  28. Schuster SR, Pockaj BA, Bothe MR, David PS, Northfelt DW. Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report. J Pers Med. 2012; 2(3):71-6.
  29. Reinholz MM, Kitzmann KA, Tenner K, Hillman D, Dueck AC, Hobday TJ, Northfelt DW, Moreno-Aspitia A, Roy V, LaPlant B, Allred JB, Stella PJ, Lingle WL, Perez EA. Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437. Clin Cancer Res. 2011 Nov 15; 17(22):7183-93. Epub 2011 Oct 05.
    View PubMed
  30. Billar JA, Dueck AC, Stucky CC, Gray RJ, Wasif N, Northfelt DW, McCullough AE, Pockaj BA. Triple-negative breast cancers: unique clinical presentations and outcomes. Ann Surg Oncol. 2010 Oct; 17 Suppl 3:384-90. Epub 2010 Sep 19.
    View PubMed
  31. Pockaj BA, Wasif N, Dueck AC, Wigle DA, Boughey JC, Degnim AC, Gray RJ, McLaughlin SA, Northfelt DW, Sticca RP, Jakub JW, Perez EA. Metastasectomy and surgical resection of the primary tumor in patients with stage IV breast cancer: time for a second look? Ann Surg Oncol. 2010 Sep; 17(9):2419-26. Epub 2010 Mar 16.
    View PubMed
  32. Ingle JN, Buzdar AU, Schaid DJ, Goetz MP, Batzler A, Robson ME, Northfelt DW, Olson JE, Perez EA, Desta Z, Weintraub RA, Williard CV, Flockhart DA, Weinshilboum RM. Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer. Cancer Res. 2010 Apr 15; 70(8):3278-86. Epub 2010 Mar 30.
    View PubMed
  33. Tan WW, Hillman DW, Salim M, Northfelt DW, Anderson DM, Stella PJ, Niedringhaus R, Bernath AM, Gamini SS, Palmieri F, Perez EA. N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial. Ann Oncol. 2010 Mar; 21(3):493-7. Epub 2009 Jul 22.
    View PubMed
  34. Kearns AE, Northfelt DW, Dueck AC, Atherton PJ, Dakhil SR, Rowland KM Jr, Fuloria J, Flynn PJ, Dentchev T, Loprinzi CL. Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8. Support Care Cancer. 2010 Mar; 18(3):321-8. Epub 2009 May 27.
    View PubMed
  35. Curtis KK, Hartney JT, Jewell RC, Park JW, Lebowitz PF, Griffin PP, Borad MJ, Fitch TR, Northfelt DW. A phase I study to characterize the safety, tolerability, and pharmacokinetics of topotecan at 4 mg/m2 administered weekly as a 30-minute intravenous infusion in patients with cancer. J Clin Pharmacol. 2010 Mar; 50(3):268-75. Epub 2009 Oct 06.
    View PubMed
  36. Cheville AL, Sloan JA, Northfelt DW, Jillella AP, Wong GY, Bearden Iii Jd, Liu H, Schaefer PL, Marchello BT, Christensen BJ, Loprinzi CL. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB). Support Care Cancer. 2009 Apr; 17(4):451-60. Epub 2009 Jan 13.
    View PubMed
  37. Tan W, Hillman D, Salim M, Northfelt D, Anderson D, Stella P, Niedringhaus R, Bernath Jr. A, Gamini S, Palmieri F, Perez E. N0332 Phase 2 Trial of Weekly Irinotecan Hydrochloride and Docetaxel in Refractory Metastatic Breast Cancer: A North Central Cancer Treatment Group (NCCTG) Trial. Ann Oncol. 2009:(Published On-Line).
    View PubMed
  38. Curtis KK, Connolly MK, Northfelt DW. Live, attenuated varicella zoster vaccination of an immunocompromised patient. J Gen Intern Med. 2008 May; 23(5):648-9. Epub 2008 Feb 20.
    View PubMed
  39. Okuno SH, Delaune R, Sloan JA, Foster NR, Maurer MJ, Aubry MC, Rowland KM Jr, Soori GS, Nikcevich DA, Kardinal CG, Northfelt DW, Adjei AA, North Central Cancer Treatment Group. A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021. Cancer. 2008 Apr 15; 112(8):1772-9.
    View PubMed
  40. Sengupta PP, Northfelt DW, Gentile F, Zamorano JL, Khandheria BK. Trastuzumab-induced cardiotoxicity: heart failure at the crossroads. Mayo Clin Proc. 2008 Feb; 83(2):197-203.
    View PubMed
  41. Kelly SV, Burke RF, Lee KS, Torloni AS, Lee RW, Northfelt D, Fonseca R. Acute myocardial infarction: an unusual presentation of essential thrombocytosis in a 17-year-old man. Clin Adv Hematol Oncol. 2008 Feb; 6(2):133-6.
    View PubMed
  42. Cheville A, Sloan J, Northfelt D, Jillella A, Wong G, Bearden J, Liu H, Schaefer P, Marchello B, Christensen B, Loprinzi C. The Efficacy of Lidocaine Patch in the Management of Postsurgical Neuropathic Pain in Patients with Cancer: A Phase III Double-Blind, Crossover Study (N01CB). J Pain Symp Manag. 2008.
    View PubMed
  43. Okuno S, Delaune R, Sloan J, Foster N, Maurer M, Aubry M, Rowland K, Soori G, Nikcevich D, Kardinal C, Northfelt D, Adjei A A Phase II Study of Gemcitabine and Epirubicin for the Treatment of Pleural Mesothelioma: A North Central Cancer Treatment Study, N0021 Cancer. 2008; 112:1772 - 1779.
    View PubMed
  44. Udhrain A, Skubitz KM, Northfelt DW. Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma. Int J Nanomedicine. 2007; 2(3):345-52.
    View PubMed
  45. Schild SE, McGinnis WL, Graham D, Hillman S, Fitch TR, Northfelt D, Garces YI, Shahidi H, Tschetter LK, Schaefer PL, Adjei A, Jett J. Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006 Jul 15; 65(4):1106-11. Epub 2006 May 26.
    View PubMed
  46. Mandrekar SJ, Northfelt DW, Schild SE, Foster NR, Bot B, Marks RS, Mailliard JA, Krook JE, Maksymiuk AW, Adjei AA, Jett JR. Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trials. J Thorac Oncol. 2006 Jul; 1(6):556-63.
    View PubMed
  47. Hunt KS, Northfelt DW. Incorporating genetic counseling into primary care practice. Resident & Staff Physician. 2006 Apr; 52(4):36-42.
  48. Chong G, Bhatnagar A, Cunningham D, Cosgriff TM, Harper PG, Steward W, Bridgewater J, Moore M, Cassidy J, Coleman R, Coxon F, Redfern CH, Jones JJ, Hawkins R, Northfelt D, Sreedharan S, Valone F, Carmichael J. Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer. Ann Oncol. 2006 Mar; 17(3):437-42. Epub 2005 Nov 25.
    View PubMed
  49. Curtis KK, Northfelt DW. 74-year-old woman with dyspnea on exertion and anemia. Mayo Clin Proc. 2006 Mar; 81(3):393-6.
    View PubMed
  50. Campbell NE, Garvey PB, Northfelt DW, Leighton JA, Heppell JP. Management of severe gastrointestinal bleeding in a patient with acquired Von Willebrand disease complicating enteropathic-associated T-cell lymphoma. Pract Gastroenterol. 2006; 30(3):76-8.
    View PubMed
  51. Harris TJ, Northfelt DW. Chemotherapy error: practical approaches to increasing patient safety. J Patient Safety. 2005 Dec; 1(4):215-219.
  52. Schild SE, Wong WW, Vora SA, Halyard MY, Northfelt DW, Kogut HL, Wheeler RH. The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005 Aug 1; 62(5):1432-7.
    View PubMed
  53. Krown SE, Northfelt DW, Osoba D, Stewart JS. Use of liposomal anthracyclines in Kaposi's sarcoma. Semin Oncol. 2004 Dec; 31(6 Suppl 13):36-52.
    View PubMed
  54. Pegram MD, Pienkowski T, Northfelt DW, Eiermann W, Patel R, Fumoleau P, Quan E, Crown J, Toppmeyer D, Smylie M, Riva A, Blitz S, Press MF, Reese D, Lindsay MA, Slamon DJ. Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer. J Natl Cancer Inst. 2004; 96:759-69.
    View PubMed
  55. Lalezari JP, DeJesus E, Northfelt DW, Richmond G, Wolfe P, Haubrich R, Henry D, Powderly W, Becker S, Thompson M, Valentine F, Wright D, Carlson M, Riddler S, Haas FF, DeMasi R, Sista PR, Salgo M, Delehanty J. A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults. Antiviral Therapy. 2003 Aug; 8(4):279-87.
    View PubMed
  56. Smith RE, Tchekmedyian NS, Chan D, Meza LA, Northfelt DW, Patel R, Austin M, Colowick AB, Rossi G, Glaspy J. A dose- and schedule-finding study of darbepoetin alpha for the treatment of chronic anaemia of cancer. Br J Cancer. 2003 Jun 16; 88(12):1851-8.
    View PubMed
  57. Bernstein ZP, Chanan-Khan A, Miller KC, Northfelt DW, Lopez-Berestein G, Gill PS. A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Cancer. 2002 Dec 15; 95(12):2555-61.
    View PubMed
  58. Palangio M, Northfelt DW, Portenoy RK, Brookoff D, Doyle RT Jr, Dornseif BE, Damask MC. Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain. Journal of Pain & Symptom Management. 2002 May; 23(5):355-68.
    View PubMed
  59. Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA, Friedman-Kien A, Kaplan LD, DuMond C, Mamelok RD, Henry DH. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. Classic Papers and Current Comments. 2002; 7:878-84.
    View PubMed
  60. Osoba D, Northfelt DW, Budd DW, Himmelberger D. Effect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma: a randomized trial of pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine. Cancer Invest. 2001; 19(6):573-80.
    View PubMed
  61. Walmsley S, Northfelt DW, Melosky B, Conant M, Friedman-Kien AE, Wagner B. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group. J Acquir Immune Defic Syndr. 1999 Nov 1; 22(3):235-46.
    View PubMed
  62. Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA, Friedman-Kien A, Kaplan LD, Du Mond C, Mamelok RD, Henry DH. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. J Clin Oncol. 1998 Jul; 16(7):2445-51.
    View PubMed
  63. Lalezari JP, Holland GN, Kramer F, McKinley GF, Kemper CA, Ives DV, Nelson R, Hardy WD, Kuppermann BD, Northfelt DW, Youle M, Johnson M, Lewis RA, Weinberg DV, Simon GL, Wolitz RA, Ruby AE, Stagg RJ, Jaffe HS. Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1; 17(4):339-44.
    View PubMed
  64. Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP, Herndier B, Northfelt DW, Huang J, Tulpule A, Levine AM. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med. 1997 Jun 5; 336(23):1641-8.
    View PubMed
  65. Levine AM, Tulpule A, Tessman D, Kaplan L, Giles F, Luskey BD, Scadden DT, Northfelt DW, Silverberg I, Wernz J, Espina B, Von Hoff D. Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial. J Clin Oncol. 1997 Mar; 15(3):1094-103.
    View PubMed
  66. Amantea MA, Forrest A, Northfelt DW, Mamelok R. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma. Clinical Pharmacology & Therapeutics. 1997 Mar; 61(3):301-11.
    View PubMed
  67. Northfelt DW, Dezube BJ, Thommes JA, Levine R, Von Roenn JH, Dosik GM, Rios A, Krown SE, DuMond C, Mamelok RD. Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy. J Clin Oncol. 1997 Feb; 15(2):653-9.
    View PubMed
  68. Northfelt DW. Liposomal anthracycline chemotherapy in the treatment of AIDS-related Kaposi's sarcoma. Oncology. 1997; 11(Suppl 11):21-32.
  69. Northfelt DW. Liposome-encapsulated anthracycline chemotherapy for AIDS-related Kaposi's sarcoma. The AIDS Reader. 1997; 7:201-7.
  70. Northfelt DW, Swift PS, Palefsky JM. Anal neoplasia. Pathogenesis, diagnosis, and management. Hematol Oncol Clin North Am. 1996 Oct; 10(5):1177-87.
    View PubMed
  71. Northfelt DW. Anal neoplasia in persons with HIV infection. AIDS Clin Care. 1996 Aug; 8(8):63-6.
    View PubMed
  72. Northfelt DW, Martin FJ, Working P, Volberding PA, Russell J, Newman M, Amantea MA, Kaplan LD. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol. 1996 Jan; 36(1):55-63.
    View PubMed
  73. Northfelt DW. Human papillomavirus-associated malignancies. Opportunistic complications of HIV. 1996; 5:28-36.
  74. Timmerman JM, Northfelt DW, Small EJ. Malignant germ cell tumors in men infected with the human immunodeficiency virus: natural history and results of therapy. J Clin Oncol. 1995 Jun; 13(6):1391-7.
    View PubMed
  75. Hambleton J, Aragon T, Modin G, Northfelt DW, Sande MA. Outcome for hospitalized patients with fever and neutropenia who are infected with the human immunodeficiency virus. Clin Infect Dis. 1995 Feb; 20(2):363-71.
    View PubMed
  76. Northfelt DW, Charlebois ED, Mirda MI, Child C, Kaplan LD, Abrams DI. Continuous low-dose interferon-alpha therapy for HIV-related immune thrombocytopenic purpura. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 1; 8(1):45-50.
    View PubMed
  77. Gowdey G, Lipsey LR, Lee R, Jacques C, Northfelt DW. Gingival mass lesions in a patient with HIV infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Jan; 79(1):7-9.
    View PubMed
  78. Gowdey G, Lipsey LR, Lee R, Jacques C, Northfelt DW. Clinicopathologic conference: gingival mass lesions in a patient with HIV infection. Oral Surg Oral Med Oral Pathol. 1995; 79:7-9.
  79. Northfelt DW. Treatment of Kaposi's sarcoma. Current guidelines and future perspectives. Drugs. 1994 Oct; 48(4):569-82.
    View PubMed
  80. Gunthel CJ, Northfelt DW. Cancers not associated with immunodeficiency in HIV infected persons. Oncology (Huntington) 1994 Jul; 8(7):59-64; discussion 64, 67-8, 70.
    View PubMed
  81. Northfelt DW. Cervical and anal neoplasia and HPV infection in persons with HIV infection. Oncology (Huntington) 1994 Jan; 8(1):33-7; discussion 38-40.
    View PubMed
  82. Collier AC, Coombs RW, Fischl MA, Skolnik PR, Northfelt D, Boutin P, Hooper CJ, Kaplan LD, Volberding PA, Davis LG, et al. Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection. Ann Intern Med. 1993 Oct 15; 119(8):786-93.
    View PubMed
  83. Lipsey LR, Northfelt DW. Anogenital neoplasia in patients with HIV infection. Curr Opin Oncol. 1993 Sep; 5(5):861-6.
    View PubMed
  84. Jacobson MA, Yajko D, Northfelt D, Charlebois E, Gary D, Brosgart C, Sanders CA, Hadley WK. Randomized, placebo-controlled trial of rifampin, ethambutol, and ciprofloxacin for AIDS patients with disseminated Mycobacterium avium complex infection. J Infect Dis. 1993 Jul; 168(1):112-9.
    View PubMed
  85. Northfelt DW, Sollitto RA, Miller TR, Hollander H. Cytomegalovirus pneumonitis. An unusual cause of pulmonary nodules in a patient with AIDS. Chest. 1993 Jun; 103(6):1918-20.
    View PubMed
  86. Heinic GS, Northfelt DW, Greenspan JS, MacPhail LA, Greenspan D. Concurrent oral cytomegalovirus and herpes simplex virus infection in association with HIV infection. A case report. Oral Surg Oral Med Oral Pathol. 1993 Apr; 75(4):488-94.
    View PubMed
  87. Northfelt DW. Mycobacterium avium complex infection in AIDS: clinical presentation, diagnosis, and current therapy. The AIDS Reader. 1993; 3:40-6.
  88. Duvic M, Kaplan LD, Northfelt DW, Siegel BJ. When AIDS patients get cancer. Patient Care. 1993; 27:77-96.
  89. Northfelt DW. Evaluation and treatment of later manifestations of HIV infection. Prim Care. 1992 Mar; 19(1):57-85.
    View PubMed
  90. Kahn JO, Northfelt DW, Miles SA. AIDS-associated Kaposi's sarcoma. AIDS Clin Rev. 1992; 261-80.
    View PubMed
  91. Northfelt DW, Palefsky JM. Human papillomavirus-associated anogenital neoplasia in persons with HIV infection. AIDS Clin Rev. 1992; 241-59.
    View PubMed
  92. Northfelt DW. AIDS-related Kaposi's sarcoma. AIDSFILE. 1992; 6:1-4.
  93. Northfelt DW, Volberding PA. Rationale for early antiviral therapy for HIV infection. HIV: Advances in Research and Therapy. 1992; 2:18-24.
  94. Northfelt DW, Kaplan LD, Abrams DI. Continuous, low-dose therapy with interferon-alpha for human immunodeficiency virus (HIV)-related immune thrombocytopenic purpura. Am J Hematol. 1991 Nov; 38(3):238-9.
    View PubMed
  95. Kahn J, Northfelt D, Volberding P. Chemotherapy for AIDS-associated Kaposi's sarcoma. Oncology (Huntington) 1991 Oct; 5(10):57-63; discussion 64, 67.
    View PubMed
  96. Northfelt DW, Kaplan LD. Clinical aspects of AIDS-related non-Hodgkin's lymphoma. Curr Opin Oncol. 1991 Oct; 3(5):872-80.
    View PubMed
  97. Kaplan LD, Kahn JO, Crowe S, Northfelt D, Neville P, Grossberg H, Abrams DI, Tracey J, Mills J, Volberding PA. Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial. J Clin Oncol. 1991 Jun; 9(6):929-40.
    View PubMed
  98. Northfelt DW, Kahn JO, Volberding PA. Treatment of AIDS-related Kaposi's sarcoma. Hematol Oncol Clin North Am. 1991 Apr; 5(2):297-310.
    View PubMed
  99. Northfelt DW. The Changing Face of AIDS: The Emerging Malignancies. Sande MA ed Current Opinion in Infectious Disease. 1991; 4:198-202.
  100. Northfelt DW, Kaplan LD. AIDS-Associated Non-Hodgkin's Lymphoma. Levine AM ed Current Opinion in Oncology. 1991; 3:872-80.
  101. Northfelt DW, Volberding PA. AIDS-related Kaposi's sarcoma: clinical presentation, biology, and therapy. Advances in Oncology. 1991; 7:9-17.
  102. Northfelt DW, Jacobson MA. Lung cancer in persons with human immunodeficiency virus infection. J Respir Dis. 1991; 7:358.
  103. Northfelt DW. Extrapulmonary pneumocystosis. AIDS Medical Report. 1991; 4:35-41.
  104. Northfelt DW. Human papillomavirus-associated malignancy in patients with HIV infection. AIDS Medical Report. 1991; 4:100-4.
  105. Northfelt DW. Combination antiretroviral therapy for HIV infection. AIDSFILE. 1991; 5:5-7.
  106. Northfelt DW, Mayer A, Kaplan LD, Abrams DI, Hadley WK, Yajko DM, Herndier BG. The usefulness of diagnostic bone marrow examination in patients with human immunodeficiency virus (HIV) infection. J Acquir Immune Defic Syndr. 1991; 4(7):659-66.
    View PubMed
  107. Northfelt DW, Kaplan LD. Clinical manifestations and treatment of HIV related non-Hodgkin lymphoma. Cancer Surv. 1991; 10:121-33.
    View PubMed
  108. Northfelt DW, Polsky B. Bacteremia in persons with HIV infection. AIDS Clin Rev. 1991; 59-79.
    View PubMed
  109. Northfelt DW, Clement MJ, Safrin S. Extrapulmonary pneumocystosis: clinical features in human immunodeficiency virus infection. Medicine (Baltimore) 1990 Nov; 69(6):392-8.
    View PubMed
  110. Northfelt DW. Clinical presentation and treatment of AIDS-related Kaposi's sarcoma. AIDS Medical Report. 1990; 3:99-108.
  111. Northfelt DW. Extrapulmonary pneumocystosis. AIDSFILE. 1990; 4:3-4.
  112. Hardy WD, Northfelt DW, Drake TA. Fatal, disseminated pneumocystosis in a patient with acquired immunodeficiency syndrome receiving prophylactic aerosolized pentamidine. Am J Med. 1989 Sep; 87(3):329-31.
    View PubMed
  113. Northfelt DW, Hayward RA, Shapiro MF. The acquired immunodeficiency syndrome is a primary care disease. Ann Intern Med. 1988 Nov 15; 109(10):773-5.
    View PubMed
  114. Skubitz KM, Northfelt DW, McGowan SE, Hoidal JR. Changes in the cell surface protein composition of human alveolar macrophages induced by smoking. Cancer Res. 1987 Jun 15; 47(12):3072-82.
    View PubMed
  115. Northfelt DW, DeNiro MJ, Epstein S. Hydrogen and carbon isotopic ratios of cellulose nitrate and saponifiable lipid fractions prepared from annual growth rings of California Redwood. Geochim Cosmochim Acta. 1981; 45:1895-8.